Sriram Ryali

CIK 1762893 · Chief Financial Officer · last filed 2026-02-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$537.3K

Companies

3

Total Filings

15

Lifetime Open-Market Net

$45.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRBU Chief Financial Officer 72,360 $1.59 $115.4K $24.7K 3 2026-02-20
CDXS Chief Financial Officer 175,791 $2.40 $421.9K $19.9K 3 2024-01-02
Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Chief Financial Officer 41,566 $1.73 $71.7K $1.2K 9 2022-03-14

Recent Filings · Page 2 of 2

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-03-15 Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Grant (A) +16,250 $0 EDGAR
2020-03-13 Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Grant (A) +229 $1.7K EDGAR
2019-09-06 Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Grant (A) +149 $1.4K EDGAR
2019-04-22 Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Buy (P) +1,250 $13.9K EDGAR
2019-01-04 Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Grant (A) $0 EDGAR
Showing 1115 of 15
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.